| (210) | Number of the EPO application | 20215879 |
| (220) | Filing date of the EPO application | 2016.11.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 13/2022, 2022.03.30 |
| (110) | EPO patent number | 3827845 |
| (11) | Number of the document | MD 3827845 T2 |
| (21) | Number of the application | e 2021 0542 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN BIOTECH INC., US; |
| (72) | Name(s) of inventor(s), code of the country | JANSSON Richard, US;
KUMAR Vineet, US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN BIOTECH INC., US; |
| (54) | Title of the invention | Subcutaneous formulations of anti-cd38 antibodies and their uses |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); A61K 31/4439 (2006.01.01); A61K 31/198 (2006.01.01); A61K 31/573 (2006.01.01); A61K 31/69 (2006.01.01); C07K 16/28 (2006.01.01); A61K 9/10 (2006.01.01); A61K 47/12 (2006.01.01); A61K 47/20 (2006.01.01); A61K 47/22 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.07.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.09.30 |
| (30) | Priority | 201562250016 P, 2015.11.03, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |